Base to Base biotech podcast 50: Drugs for kidney transplants, glycans, and drug delivery
Anti-cancer drug gets phase I FDA trials approval
New mass spec platform launched
Approval for prostate cancer treatment
World’s first gene-editing therapy for hyperlipidemia
Positive results for Lilly obesity drug
“Foundational moment for in vivo cell therapy”
Cooperative motor proteins kill cancer cells when dual-inhibited
SanegeneBio announces collaboration with Lilly
Amgen reveals cardiovascular drug results
Pila Pharma’s capital raise oversubscribed by 293% to fund obesity studies
Base to Base biotech podcast 34: World Immunization Day and infertility